{"id":2068,"date":"2017-10-24T23:22:08","date_gmt":"2017-10-24T23:22:08","guid":{"rendered":"http:\/\/www.getbetterbodysystem.com\/fat-loss-tips\/abbvie-bets-on-alzheimers-immunotherapy-with-big-biotech-deal\/"},"modified":"2017-10-24T23:22:08","modified_gmt":"2017-10-24T23:22:08","slug":"abbvie-bets-on-alzheimers-immunotherapy-with-big-biotech-deal","status":"publish","type":"post","link":"http:\/\/www.getbetterbodysystem.com\/fat-loss-tips\/abbvie-bets-on-alzheimers-immunotherapy-with-big-biotech-deal\/","title":{"rendered":"AbbVie bets on Alzheimer&#8217;s immunotherapy with big biotech deal"},"content":{"rendered":"<p>(Reuters) &#8211; U.S. drugmaker AbbVie is betting on the potential of the body&#8217;s immune system to fight Alzheimer&#8217;s by signing a drug development deal worth more than $  200 million with unlisted biotech company Alector.<\/p>\n<div class=\"feedflare\"><a href=\"http:\/\/feeds.reuters.com\/~ff\/reuters\/healthNews?a=sFnV3cRRed0:07DBUxruiaE:yIl2AUoC8zA\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/reuters\/healthNews?d=yIl2AUoC8zA\" border=\"0\" title=\"\" alt=\"\" \/><\/img><\/a> <a href=\"http:\/\/feeds.reuters.com\/~ff\/reuters\/healthNews?a=sFnV3cRRed0:07DBUxruiaE:F7zBnMyn0Lo\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/reuters\/healthNews?i=sFnV3cRRed0:07DBUxruiaE:F7zBnMyn0Lo\" border=\"0\" title=\"\" alt=\"\" \/><\/img><\/a> <a href=\"http:\/\/feeds.reuters.com\/~ff\/reuters\/healthNews?a=sFnV3cRRed0:07DBUxruiaE:V_sGLiPBpWU\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/reuters\/healthNews?i=sFnV3cRRed0:07DBUxruiaE:V_sGLiPBpWU\" border=\"0\" title=\"\" alt=\"\" \/><\/img><\/a> <\/div>\n<p><img decoding=\"async\" loading=\"lazy\" src=\"http:\/\/feeds.feedburner.com\/~r\/reuters\/healthNews\/~4\/sFnV3cRRed0\" height=\"1\" width=\"1\" alt=\"\" \/><br \/>\n<a rel=\"nofollow\" href=\"http:\/\/feeds.reuters.com\/~r\/reuters\/healthNews\/~3\/sFnV3cRRed0\/abbvie-bets-on-alzheimers-immunotherapy-with-big-biotech-deal-idUSKBN1CT1NT\">Reuters: Health News<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>(Reuters) &#8211; U.S. drugmaker AbbVie is betting on the potential of the body&#8217;s immune system to fight Alzheimer&#8217;s by signing a drug development deal worth more than $ 200 million with unlisted biotech company Alector. Reuters: Health News<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[391,146,3960,3961,645,802],"_links":{"self":[{"href":"http:\/\/www.getbetterbodysystem.com\/wp-json\/wp\/v2\/posts\/2068"}],"collection":[{"href":"http:\/\/www.getbetterbodysystem.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.getbetterbodysystem.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.getbetterbodysystem.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.getbetterbodysystem.com\/wp-json\/wp\/v2\/comments?post=2068"}],"version-history":[{"count":0,"href":"http:\/\/www.getbetterbodysystem.com\/wp-json\/wp\/v2\/posts\/2068\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.getbetterbodysystem.com\/wp-json\/wp\/v2\/media?parent=2068"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.getbetterbodysystem.com\/wp-json\/wp\/v2\/categories?post=2068"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.getbetterbodysystem.com\/wp-json\/wp\/v2\/tags?post=2068"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}